Dimerix Ltd (ASX:DXB, OTC:SBMJF) has moved to strengthen the clinical and regulatory footing of its lead kidney disease ...
At NAB 2026 in Las Vegas, Aputure was showing the new Sidus Link Pro 2.3 update. Sidus Link Pro 2.3 is an update to its ...
Q1 2026 Earnings Call May 4, 2026 4:30 PM EDTCompany ParticipantsTraci McCarty - Group Vice PresidentAlexander Hardy ...
Stockhead on MSN
Health Check: Syntara goes to the well for $10 million to fund advanced cancer trial
Myelofibrosis drug developer Syntara has gone to the well for $10m, the latest biotech to tap the market in a ... Read More ...
Clinuvel Pharmaceuticals (ASX:CUV) is conducting a Phase III trial to expand the indications for Scenesse (afamelanotide), ...
Aiper, the world's No.1 smart robotic pool cleaner brand[1] and leader in smart yard innovation, today announced its global ...
Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a ...
Marvin T. Milk a.k.a. MM from The Boys is the group's level-headed, loving, and oft-frustrated medic with a God-tier T-Shirt ...
A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
In a volatile market, Morgans healthcare analyst Iain Wilkie told Stockhead upcoming catalysts were likely to remain a key ...
Wolters Kluwer, a global leader in professional information, software solutions and services, today announced two new AI-powered enhancements to its Financial & Corporate Compliance (FCC) portfolio: ...
Ahead of Thursday's end-of-month cut-off, March quarter reports are flowing faster than the florid prose of the captive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results